Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Hengfengqiang Bio-Technology, often referred to as Jiangsu Hengfeng Pharmaceutical in international contexts, is a prominent Chinese enterprise specializing in the research, development, and manufacturing of animal health products. The company operates high-standard GMP-certified facilities producing a wide range of veterinary pharmaceuticals, including injections, powders, and premixes. Its product portfolio primarily targets livestock and poultry, focusing on anti-infectives, antiparasitics, and nutritional supplements. Hengfengqiang is recognized as a High-Tech Enterprise in China and maintains a significant presence in both domestic and international veterinary medicine markets.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Jiangsu Hengfeng Pharmaceutical.